NO20084542L - Farmasoytisk kombinasjon inneholdende 3-(3-dimetylamino-1-etyl-2-metyl-propyl)-fenol og paracetamol - Google Patents

Farmasoytisk kombinasjon inneholdende 3-(3-dimetylamino-1-etyl-2-metyl-propyl)-fenol og paracetamol

Info

Publication number
NO20084542L
NO20084542L NO20084542A NO20084542A NO20084542L NO 20084542 L NO20084542 L NO 20084542L NO 20084542 A NO20084542 A NO 20084542A NO 20084542 A NO20084542 A NO 20084542A NO 20084542 L NO20084542 L NO 20084542L
Authority
NO
Norway
Prior art keywords
paracetamol
dimethylamino
phenol
propyl
ethyl
Prior art date
Application number
NO20084542A
Other languages
English (en)
Other versions
NO341602B1 (no
Inventor
Klaus Schiene
Petra Bloms-Funke
Original Assignee
Gruenenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37025148&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20084542(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh
Publication of NO20084542L publication Critical patent/NO20084542L/no
Publication of NO341602B1 publication Critical patent/NO341602B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Det er beskrevet en kombinasjon omfattende som komponenter (a) forbindelsen 3-(3dimetylamino-1-etyl-2-metyl-propyl)-fenol og (b) paracetamol eller et derivat derav, et farmasøytisk preparat og en doseringsform omfattende nevnte kombinasjon så vel som en fremgangsmåte for behandling av smerte, for eksempel kronisk eller akutt smerte, kjennetegnet ved at komponenter (a) og (b) administreres samtidig eller trinnvis til et pattedyr, hvori komponent (a) kan administreres før eller komponent (b) og hvori komponentene (a) eller (b) administreres til pattedyret enten via samme eller forskjellig administrasjonsvei.
NO20084542A 2006-04-28 2008-10-28 Farmasøytisk kombinasjon omfattende 3-(3-dimetylamino-1-etyl-2-metyl-propyl)-fenol og paracetamol NO341602B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06008851 2006-04-28
PCT/EP2007/003632 WO2007128413A1 (en) 2006-04-28 2007-04-25 Pharmaceutical combination comprising 3- ( 3-dimethylamino-1-ethyl-2-methyl-propyl) -phenol and paracetamol

Publications (2)

Publication Number Publication Date
NO20084542L true NO20084542L (no) 2008-10-28
NO341602B1 NO341602B1 (no) 2017-12-11

Family

ID=37025148

Family Applications (2)

Application Number Title Priority Date Filing Date
NO20084542A NO341602B1 (no) 2006-04-28 2008-10-28 Farmasøytisk kombinasjon omfattende 3-(3-dimetylamino-1-etyl-2-metyl-propyl)-fenol og paracetamol
NO20171831A NO343505B1 (no) 2006-04-28 2017-11-17 Farmasøytisk kombinasjon omfattende 3-(3-dimetylamino-1-etyl-2-metylpropyl)-fenyl og paracetamol

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO20171831A NO343505B1 (no) 2006-04-28 2017-11-17 Farmasøytisk kombinasjon omfattende 3-(3-dimetylamino-1-etyl-2-metylpropyl)-fenyl og paracetamol

Country Status (24)

Country Link
EP (1) EP2012764B1 (no)
JP (2) JP5496653B2 (no)
KR (1) KR101396166B1 (no)
CN (1) CN101431990B (no)
AT (1) ATE494889T1 (no)
AU (1) AU2007247481B2 (no)
BR (1) BRPI0710682B8 (no)
CA (1) CA2650423C (no)
CY (1) CY1111369T1 (no)
DE (1) DE602007011913D1 (no)
DK (1) DK2012764T3 (no)
EC (2) ECSP088793A (no)
ES (1) ES2356093T3 (no)
HR (1) HRP20110076T1 (no)
IL (1) IL194883A (no)
MX (1) MX2008013779A (no)
NO (2) NO341602B1 (no)
NZ (1) NZ571442A (no)
PL (1) PL2012764T3 (no)
PT (1) PT2012764E (no)
RU (1) RU2442576C2 (no)
SI (1) SI2012764T1 (no)
WO (1) WO2007128413A1 (no)
ZA (1) ZA200810124B (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007012165A1 (de) * 2007-03-12 2008-09-18 Grünenthal GmbH Verwendung von 1-Phenyl-3-dimethylamino-propanverbindungen zur Therapie des Neuropathieschmerzes
CN102908339A (zh) * 2007-11-23 2013-02-06 格吕伦塔尔有限公司 他喷他多组合物
SI2582366T1 (sl) 2010-06-15 2016-02-29 Gruenenthal Gmbh Farmacevtska kombinacija za zdravljenje bolečine
CA2828635C (en) * 2011-03-04 2020-01-14 Grunenthal Gmbh Parenteral administration of tapentadol
RS56692B1 (sr) 2011-03-04 2018-03-30 Gruenenthal Gmbh Polučvrsta vodena farmaceutska kompozicija koja sadrži tapentadol
KR101946790B1 (ko) 2011-03-04 2019-02-13 그뤼넨탈 게엠베하 경구 투여를 위한 타펜타돌의 수성 약제학적 제형
US9320729B2 (en) 2012-05-18 2016-04-26 Gruenenthal Gmbh Pharmaceutical composition comprising (1r,4r)-6′-flouro-N,N-dimethyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano-[3,4,b]indol]-4-amine and a propionic acid derivative
US20130310385A1 (en) 2012-05-18 2013-11-21 Gruenenthal Gmbh Pharmaceutical Composition Comprising (1r,4r)-6'-fluoro-N,N-dimethyl-4-phenyl-4',9'-dihydro-3'H-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine and Antidepressants
US20130310435A1 (en) * 2012-05-18 2013-11-21 Gruenenthal Gmbh Pharmaceutical Composition Comprising (1r,4r)-6'-fluoro-N, N-dimethyl-4-phenyl-4,9' -dihydro-3'H-spiro[cyclohexane-1,1' -pyrano[3,4,b]indol]-4-amine and Paracetamol or Propacetamol
US9855286B2 (en) 2012-05-18 2018-01-02 Gruenenthal Gmbh Pharmaceutical composition comprising (1r,4r)-6′-fluoro-N,N-di methyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano-[3,4,b]indol]-4-amine and a salicylic acid component
EP2808319A1 (en) 2013-05-31 2014-12-03 Arevipharma GmbH 3-[3-(Dimethylamino)-1-ethyl-2-methylpropyl]phenol resin complex
EP3273953B1 (en) 2015-03-27 2019-01-02 Grünenthal GmbH Stable formulation for parenteral administration of tapentadol
CN109996533A (zh) 2016-09-23 2019-07-09 格吕伦塔尔有限公司 用于肠胃外施用他喷他多的稳定制剂
WO2018153947A1 (en) 2017-02-23 2018-08-30 Grünenthal GmbH Tapentadol as local anesthetic

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4426245A1 (de) * 1994-07-23 1996-02-22 Gruenenthal Gmbh 1-Phenyl-3-dimethylamino-propanverbindungen mit pharmakologischer Wirkung
PE20030527A1 (es) * 2001-10-24 2003-07-26 Gruenenthal Chemie Formulacion farmaceutica con liberacion retardada que contiene 3-(3-dimetilamino-1-etil-2-metil-propil) fenol o una sal farmaceuticamente aceptable del mismo y tabletas para administracion oral que la contienen
PT1562567T (pt) * 2002-11-22 2017-08-24 Gruenenthal Gmbh Combinação de analgésicos selecionados e inibidores da cox-ii

Also Published As

Publication number Publication date
HRP20110076T1 (hr) 2011-02-28
RU2008146816A (ru) 2010-06-10
IL194883A0 (en) 2009-08-03
PT2012764E (pt) 2011-02-02
SI2012764T1 (sl) 2011-03-31
DK2012764T3 (da) 2011-02-28
CA2650423C (en) 2014-08-12
CA2650423A1 (en) 2007-11-15
JP2013213045A (ja) 2013-10-17
AU2007247481B2 (en) 2013-02-14
EP2012764B1 (en) 2011-01-12
NO20171831A1 (no) 2008-10-28
RU2442576C2 (ru) 2012-02-20
JP5496653B2 (ja) 2014-05-21
ECSP17000643A (es) 2018-06-30
JP2009535313A (ja) 2009-10-01
CY1111369T1 (el) 2015-08-05
WO2007128413A1 (en) 2007-11-15
BRPI0710682A2 (pt) 2011-08-23
ATE494889T1 (de) 2011-01-15
ECSP088793A (es) 2008-11-27
IL194883A (en) 2012-10-31
BRPI0710682B1 (pt) 2020-09-24
EP2012764A1 (en) 2009-01-14
PL2012764T3 (pl) 2011-04-29
KR20090006219A (ko) 2009-01-14
ES2356093T3 (es) 2011-04-04
HK1127289A1 (en) 2009-09-25
NO341602B1 (no) 2017-12-11
NO343505B1 (no) 2019-03-25
CN101431990A (zh) 2009-05-13
ZA200810124B (en) 2009-08-26
CN101431990B (zh) 2011-08-03
DE602007011913D1 (de) 2011-02-24
NZ571442A (en) 2011-09-30
KR101396166B1 (ko) 2014-05-27
BRPI0710682B8 (pt) 2021-05-25
AU2007247481A1 (en) 2007-11-15
MX2008013779A (es) 2008-11-14

Similar Documents

Publication Publication Date Title
NO20084542L (no) Farmasoytisk kombinasjon inneholdende 3-(3-dimetylamino-1-etyl-2-metyl-propyl)-fenol og paracetamol
IL194885A0 (en) Pharmaceutical combination comprising 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol and an nsaid
AU2016219643A1 (en) Pharmaceutical combination for the treatment of pain
CY1121492T1 (el) Φαρμακευτικος συνδυασμος 3-(3-διμεθυλαμινο-1-αιθυλ-2-μεθυλ-προπυλ)-φαινολης και πρεγκαμπαλινης ή γκαμπαπεντινης
EA201300121A1 (ru) Ингибитор дпп-4 в комбинации с дополнительным противодиабетическим агентом, таблетки, включающие указанные композиции, их применение и способ их получения
CY1118661T1 (el) Φαρμακευτικη συνθεση, φαρμακευτικη δοσολογικη μορφη, διαδικασια για την παρασκευη τους, μεθοδοι για αντιμετωπιση και χρησεις αυτων
NO20074999L (no) Metode og preparat for behandling av perifere vaskulaere sykdommer
CY1119140T1 (el) Συνθεσεις αντικωδικευσης και μεθοδοι κατασκευης και χρησης τους
WO2007143607A3 (en) Method of treating atrophic vaginitis
EA200802166A1 (ru) Стабильная фармацевтическая композиция с защитным действием от раздражения (варианты), способ ее получения и способ лечения кальций-миметиком с ее помощью
NO20083885L (no) Fremgangsmate for behandling av inflammatoriske sykdommer
EA201070477A1 (ru) Транс-кломифен для лечения метаболического синдрома
WO2008148074A3 (en) Inhibitors of mtor and methods of treatment using same
NO20084256L (no) DPP IV inhibitorformuleringer
WO2007070052A3 (en) Pharmaceutical compositions and methods for treating or preventing oxalate-related disease
WO2007125501A3 (en) Liquid compositions comprising phenylephrine and acetaminophen and their use for the treatment of respiratory illness
BRPI0622054B8 (pt) composto e composição farmacêutica
UA116871C2 (uk) СПОСІБ ЛІКУВАННЯ МІЄЛОДИСПЛАСТИЧНОГО СИНДРОМУ, ТАЛАСЕМІЇ ТА СЕРПОПОДІБНО-КЛІТИННОЇ АНЕМІЇ ЗА ДОПОМОГОЮ ЗАСТОСУВАННЯ АНТАГОНІСТА АКТИВІНУ ПОЛІПЕПТИДУ ActRII
BRPI0922789A2 (pt) peptídeo de ligação de albumina intermediador para reconhecimento de doença
EA200901237A1 (ru) Применение димирацетама при лечении хронической боли
WO2008070010A3 (en) Hydroxylamine derivatives for the treatment of stroke
EA200901062A1 (ru) Использование ингибиторов растворимой эпоксидгидролазы для предотвращения и лечения метаболического синдрома и соответствующих расстройств
CL2007003284A1 (es) Composicion farmaceutica que comprende una asociacion de i) ciclobenzaprina, ii) aceclofenaco y opcionalmente iii) excipientes; y su uso para el tratamiento de enfermedades musculares dolorosas.
EA200701086A1 (ru) Производные изоксазола, их фармацевтические композиции и способ лечения невропатической боли